For the new study, researchers used a “secret-shopper” method to attempt to schedule an appointment for a patient weighing ...

A large genome-wide analysis reports that common obesity traits share, and in some cases drive, risk for diabetic kidney ...

Drugs like Ozempic and Wegovy, already popular for diabetes and weight loss, may also lower the risk of some cancers, ...

Thousands of NHS patients are believed to be missing out. And with the NHS tightly restricting access, some working in the ...

MET-097i’s mid-stage performance “bodes well” for Pfizer’s buyout bid for Metsera, according to BMO Capital Markets, a deal ...

In the SIBAMATE study, more than 60% of patients lost at least 5% of body weight after 3 months of using ...

Novo Nordisk NVO has achieved tremendous commercial success with its blockbuster semaglutide products, Wegovy (for obesity) and Ozempic (for diabetes). However, the company’s growth trajectory has ...

Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing ...

East Carroll Parish had the highest prevalence of obesity, while St. Tammany and Lafayette parishes had the lowest. How did ...

Cannabidiol (CBD) shows promise in regulating appetite, glucose and lipid metabolism, and inflammation in preclinical models ...

Closing adds $5 million in marketable securities, strengthens financial position, and complements MIRA's advancing programs ...

A recent study revealed that individuals suffering from severe obesity usually face discrimination in health care, with many ...